These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8633545)

  • 1. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy.
    Jamal H; Regenstein F; Farr G; Perrillo RP
    Am J Gastroenterol; 1996 May; 91(5):1027-30. PubMed ID: 8633545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
    Davies SE; Portmann BC; O'Grady JG; Aldis PM; Chaggar K; Alexander GJ; Williams R
    Hepatology; 1991 Jan; 13(1):150-7. PubMed ID: 1988336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
    Roche B; Samuel D; Feray C; Majno P; Gigou M; Reynes M; Bismuth H
    Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C; Pedersen J; Uren E; Locarnini S
    Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrosing cholestatic hepatitis by B virus reactivation in AIDS].
    Poulet B; Chapel F; Dény P; Schneider MC; Jeantils V; Beaugrand M; Guettier C
    Ann Pathol; 1996; 16(3):188-91. PubMed ID: 8766176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatal fibrosing cholestatic hepatitis following renal transplantation].
    Sprengers D; van Gelder T; Zondervan PE; Niesters HG; Janssen HL; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1380-4. PubMed ID: 12162178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B in established cardiac cirrhosis--a rare indication for liver transplantation].
    Bechstein WO; Blumhardt G; Neuhaus P; Hopf U; Lobeck H
    Leber Magen Darm; 1989 Dec; 19(6):327-31. PubMed ID: 2615553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of successful treatment of fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin after liver transplantation.
    Kim B; Trivedi A; Thung SN; Grewal P
    Semin Liver Dis; 2014 Feb; 34(1):108-12. PubMed ID: 24782264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.